Trial
NCT01785459
Bupivacaine for Benign Headache in the ED
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Wake Forest University Health Sciences
Collaborators
—
Condition
Benign Headache
Intervention
0.5% bupivacaine
Why stopped
Unable to enroll adequate number of patients.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-07-14